Hims & Hers says it’s selling a GLP-1 weight loss drug for 85% less than Wegovy. Here’s the price.
Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction of the cost of brand-name competitors such as Wegovy and Ozempic. Following the announcement, shares of the telehealth company soared more than 30% Monday. Hims & Hers will provide patients with compounded GLP-1 drugs that start at
Read More